Neostigmine Methylsulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Neostigmine Methylsulfate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Jan 12, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-413-10
- Dosage Form
- Injection
- Presentation
- Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)
- Initial Posting
- Jan 12, 2026